Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hypophosphatemia.

Drug Intelligence & Clinical Pharmacy

|July 1, 1984

Summary

This summary is machine-generated.

Hypophosphatemia, a common disorder affecting all organ systems, occurs when serum phosphate levels drop below 2.5 mg%. Treatment involves identifying at-risk patients, correcting causes, and supplementing phosphate, especially intravenously for severe cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Withered Yang: a review of traditional Chinese medical treatment of male infertility and erectile dysfunction.

Journal of andrology·2001

Same author

Conflicting data in the literature: a true dilemma.

Drug intelligence & clinical pharmacy·1986

Same author

beta-Lactamase inhibitors.

Drug intelligence & clinical pharmacy·1985

Same author

Transdermal nitroglycerin: a reevaluation.

Drug intelligence & clinical pharmacy·1984

Same author

Oral gold in arthritis.

Drug intelligence & clinical pharmacy·1984

Same author

Atracurium and vecuronium: two unique neuromuscular blocking agents.

Drug intelligence & clinical pharmacy·1984

Same journal

Profile of prescription medication in a pediatric population.

Drug intelligence & clinical pharmacy·1988

Same journal

SI units in drug therapeutics.

Drug intelligence & clinical pharmacy·1988

Same journal

Physicians' review of significant interventions by clinical pharmacists in inpatient care.

Drug intelligence & clinical pharmacy·1988

Same journal

Possible interaction of ranitidine with phenytoin.

Drug intelligence & clinical pharmacy·1988

Same journal

Famotidine-associated mental confusion in elderly patients.

Drug intelligence & clinical pharmacy·1988

Same journal

Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

Drug intelligence & clinical pharmacy·1988

See all related articles

Area of Science:

Nephrology
Endocrinology
Internal Medicine

Background:

Hypophosphatemia is a common disorder with serum phosphate levels below 2.5 mg%.
It can affect virtually every organ system due to various causes like decreased intake, absorption, or increased loss.
Phosphate deficiency necessitates prompt recognition and management.

Purpose of the Study:

To outline the causes and consequences of hypophosphatemia.
To present optimal therapeutic strategies for hypophosphatemia.
To detail indications and empirical intravenous (IV) phosphate therapy for severe cases.

Main Methods:

Review of literature on hypophosphatemia.
Analysis of etiological factors contributing to phosphate deficiency.

Related Experiment Videos

Guidelines for recognizing at-risk patients and correcting underlying abnormalities.

Criteria for initiating intravenous phosphate supplementation.

Main Results:

Hypophosphatemia results from decreased phosphate intake/absorption, increased renal/nonrenal losses, or transcellular shifts.
Severe hypophosphatemia (serum phosphate < 1 mg%) requires intravenous phosphate therapy.
Close monitoring of serum phosphate, calcium, potassium, and magnesium is crucial during IV therapy.

Conclusions:

Optimal management of hypophosphatemia involves risk identification, addressing the root cause, and phosphate supplementation.
Intravenous phosphate therapy is essential for severe hypophosphatemia.
Adherence to monitoring guidelines ensures safe and effective treatment.